Device Therapy for Heart Failure and Angina

Device therapy plays a critical role in the management of advanced heart failure and refractory angina, offering life-saving options for patients who do not respond adequately to pharmacological treatment. Implantable devices such as cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillators (ICDs) have been shown to reduce mortality and improve quality of life in selected heart failure patients. CRT, in particular, improves ventricular synchrony, enhancing cardiac efficiency and reducing heart failure symptoms.

For patients with severe angina not amenable to revascularization, options such as enhanced external counterpulsation (EECP) and spinal cord stimulation (SCS) offer symptomatic relief by promoting collateral circulation and modulating pain perception. The ongoing development of novel devices, including left ventricular assist devices (LVADs) and wearable sensors for remote monitoring, continues to push the boundaries of what is possible in the treatment of heart failure and angina.

    Related Conference of Device Therapy for Heart Failure and Angina

    November 27-28, 2025

    32nd World Heartcare Summit

    Paris, France
    January 12-13, 2026

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2026

    15th World Heart Congress

    Paris, France
    March 23-24, 2026

    41st World Cardiology Conference

    London, UK
    April 08-29, 2026

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 13-14, 2026

    9th World Heart and Brain Conference

    Tokyo, Japan
    May 14-15, 2026

    5th International Conference on Cardiology

    Rome, Italy
    May 21-22, 2026

    15th World Congress on Cardiology

    London, UK
    July 29-30, 2026

    30th World Cardiology Conference

    Paris, France

    Device Therapy for Heart Failure and Angina Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in